On February 8, 2022 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, reported that Raymond J. Tesi, MD, President and CEO, will present at the BIO CEO & Investor Conference being held February 14 – 17 at the Marriott Marquis in New York City (Press release, INmune Bio, FEB 8, 2022, View Source [SID1234607895]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BIO CEO & Investor Conference
Presentation Date: Tuesday, February 15, 2022
Presentation Time: 9:15 AM Eastern Time

Please contact your representative at BIO to schedule a virtual one-on-one meeting with INmune Bio during the respective conference.